Gleevec and Clarinex drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Gleevec (imatinib mesylate) and Clarinex (desloratadine). Common drug interactions include rash among females and pruritus among males.
The phase IV clinical study analyzes what interactions people have when they take Gleevec and Clarinex. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Gleevec?
Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.
What is Clarinex?
Clarinex has active ingredients of desloratadine. It is often used in allergies. eHealthMe is studying from 6,463 Clarinex users. Check the latest studies of Clarinex.
13 people who take Gleevec and Clarinex together, and have interactions are studied.

What are the common drug interactions of Gleevec and Clarinex, by gender? *:
female:
- Rash
- Antinuclear antibody positive
- Pyrexia (fever)
- Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
- Weight increased
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Diarrhoea
- Faeces discoloured
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Hepatic enzyme increased
male:
- Pruritus (severe itching of the skin)
- Rash
- Immunosuppression
- Intracranial tumour haemorrhage (bleeding tumour in brain)
- Malignant neoplasm progression (cancer tumour came back)
- Pneumonia
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Vascular bypass dysfunction
- Skin disorder (skin disease)
- Atelectasis (partial or complete collapse of the lung)
What are the common drug interactions of Gleevec and Clarinex, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Delayed recovery from anaesthesia
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Vascular bypass dysfunction
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Abasia (inability to walk)
- Back pain
- Intervertebral disc protrusion (spinal disc protrusion)
- Intervertebral disc space narrowing (spinal disc space narrowing)
- Muscle spasms (muscle contraction)
- Muscular weakness (muscle weakness)
- Nausea (feeling of having an urge to vomit)
- Periorbital oedema (swelling around the eyes)
- Vomiting
- Death
60+:
- Rash
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Splenic lesion (lesion on spleen)
- Upper respiratory tract infection
- Wheezing (a high-pitched whistling sound made while you breath)
- Antinuclear antibody positive
- Pyrexia (fever)
- Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
- Weight increased
- Eye swelling
What are the existing conditions these people have? *
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 23.08%
- Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 15.38%
- Gastrointestinal Stromal Tumor: 2 people, 15.38%
- Tumor: 1 person, 7.69%
- Rectosigmoid Cancer (cancer that originates in the rectum and sigmoid colon): 1 person, 7.69%
- Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 7.69%
- Pain: 1 person, 7.69%
- Nausea (feeling of having an urge to vomit): 1 person, 7.69%
- Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 1 person, 7.69%
- Asplenia (absence of normal spleen function and is associated with some serious infection risks): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Gleevec and Clarinex?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Gleevec and Clarinex:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Gleevec:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clarinex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gleevec and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clarinex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O'rafferty C, McElligott F, Storey L, O'marcaigh A, Smith O, "Pneumatosis intestinalis and imatinib mesylate", Annals of hematology, 2014 Oct .
- O'rafferty C, McElligott F, Storey L, O'marcaigh A, Smith O, "Pneumatosis intestinalis and imatinib mesylate", Annals of hematology, 2014 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on imatinib mesylate and desloratadine (the active ingredients of Gleevec and Clarinex, respectively), and Gleevec and Clarinex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Actonel cause Pain Exacerbated? - 5 seconds ago
- Drug interactions of Lipitor and Retacrit - 16 seconds ago
- Drug interactions of Metrogel and Prinivil - 23 seconds ago
- Drug interactions of Betamethasone Valerate and Pioglitazone - 23 seconds ago
- Lipids Abnormal and Fainting - 26 seconds ago
- Could Primidone cause Acute Upper Airway Obstruction? - 30 seconds ago
- Could Bactrim cause Cd4 Lymphocytes Decreased? - 36 seconds ago
- Sepsis and drugs of ingredients of tucatinib - 45 seconds ago
- Drug interactions of Atorvastatin Calcium and Taltz - 51 seconds ago
- Profen and Skin Cancer - Basal Cell for Women aged 50-59 - a minute ago